Home » Stocks » HUGE

FSD Pharma Inc. (HUGE)

Stock Price: $1.42 USD -0.13 (-8.39%)
Updated Oct 30, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 21.08M
Revenue (ttm) 196,259
Net Income (ttm) -39.70M
Shares Out 14.84M
EPS (ttm) -5.63
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 30, 2020
Last Price $1.42
Previous Close $1.55
Change ($) -0.13
Change (%) -8.39%
Day's Open 1.58
Day's Range 1.38 - 1.64
Day's Volume 252,042
52-Week Range 1.38 - 14.00

More Stats

Market Cap 21.08M
Enterprise Value 16.63M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 14.84M
Float 11.66M
EPS (basic) n/a
EPS (diluted) -5.63
FCF / Share -2.07
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 75,456
Short Ratio 0.46
Short % of Float 0.65%
Beta 0.54
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 107.40
PB Ratio 0.87
Revenue 196,259
Operating Income -27.99M
Net Income -39.70M
Free Cash Flow -14.62M
Net Cash 4.44M
Net Cash / Share 0.30
Gross Margin -936.22%
Operating Margin -14,262.99%
Profit Margin -20,230.80%
FCF Margin -7,449.07%
ROA -41.75%
ROE -93.65%
ROIC -206.90%
Key stats in USD, based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (1)

Buy 1
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

Current: $1.42
Target: 11.00
*Average 12-month USD price target from 1 stock analysts.

Financial Performance

Financial numbers in millions CAD.

Financial Overview

Gross Profit-2.41-0.03
Operating Income-36.67-32.86-3.52
Net Income-52.01-22.71-3.52
Shares Outstanding7.065.912.19
Earnings Per Share-7.37-3.85-
Operating Cash Flow-18.23-18.49-0.15
Capital Expenditures-0.92-4.03-7.65
Free Cash Flow-19.15-22.52-7.80
Cash & Equivalents7.9321.134.74
Total Debt2.11--
Net Cash / Debt5.8221.134.74
Book Value48.2251.0312.41
Numbers in millions CAD, except per-share numbers.

Company Profile

Company Details

Full Name FSD Pharma Inc.
Country Canada
Employees 17
CEO Raza Bokhari

Stock Information

Ticker Symbol HUGE
Stock Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Unique Identifier NASDAQ: HUGE


FSD Pharma, through its subsidiary, FV Pharma Inc., produces medical cannabis in Canada. The company focuses on the development of indoor grown pharmaceutical grade cannabis; and research and development of various cannabinoid-based treatments for central nervous system disorders and autoimmune diseases of the skin, GI tract, and musculoskeletal system, such as chronic pain. FSD Pharma Inc. has strategic alliance agreements with SciCann Therapeutics Inc., CannTab Therapeutics, and Solarvest BioEnergy Inc. The company was founded in 1998 and is headquartered in Toronto, Canada.